Target intelligence / Profile preview

Hippocampal lipid metabolism proteins

Molecular classification
Enzyme, Transporter, Receptor, Transcription factor
01

Overview

Hippocampal lipid metabolism proteins refer to a heterogeneous group of enzymes, transporters, and signaling molecules that regulate the synthesis, transport, and degradation of lipids within the hippocampus, a brain region critical for memory and learning (PubMed: 31515443). Key members of this group include Apolipoprotein E (APOE), which serves as the primary cholesterol carrier in the central nervous system, and Cholesterol 24-hydroxylase (CYP46A1), the rate-limiting enzyme for brain cholesterol elimination (UniProt: P02649, Q9Y6A2). These proteins are essential for maintaining neuronal membrane integrity, supporting synaptogenesis, and facilitating the repair of damaged neurons (PubMed: 28435104). Dysregulation of hippocampal lipid metabolism is a hallmark of neurodegenerative diseases, particularly Alzheimer's disease, where impaired cholesterol clearance is linked to the accumulation of amyloid-beta plaques and neuroinflammation (NIH: Alzheimer's Disease Fact Sheet). While the term describes a metabolic pathway rather than a single druggable entity, individual proteins within this network, such as Liver X Receptors (LXRs) and ABCA1, are actively investigated as therapeutic targets to restore lipid balance and provide neuroprotection (PubMed: 30243432).

Other names
Brain lipid metabolism proteinsHippocampal lipid signaling proteinsNeuronal lipid homeostasis proteins
02

Mechanism of action

Modulation of specific enzymes or nuclear receptors within the lipid metabolic pathway to enhance cholesterol efflux, reduce lipid peroxidation, or promote the clearance of neurotoxic protein aggregates.

03

Biological functions

Lipid homeostasisCholesterol metabolismSynaptic plasticityNeurogenesisMyelin maintenance
04

Disease associations

Alzheimer's diseaseNeurodegenerative diseaseCognitive impairmentNiemann-Pick disease type C
05

Safety considerations

Off-target systemic lipid disruption (e.g., hypertriglyceridemia from LXR agonists)Blood-brain barrier permeability challengesPotential for neurotoxicity if cholesterol levels are excessively depletedLiver toxicity
06

Interacting drugs

Bexarotene

3 more in the full profile.

07

Biomarkers

Cerebrospinal fluid 24S-hydroxycholesterolApolipoprotein E (APOE) genotypePlasma oxysterol levelsHippocampal volume (via MRI)

Beyond the preview

Go deeper on Hippocampal lipid metabolism proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hippocampal lipid metabolism proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call